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Introduction
Chronic pancreatitis is a significant worldwide medical 
problem which can be caused by a variety of etiologies 
including toxins (alcohol), metabolic disorders (hyperlipi-
demia and hypercalcemia), and genetic disorders (cystic 
fibrosis, serine protease inhibitor Kazal type 1 (SPINK), and 
cationic trypsinogen mutations).1 Worldwide prevalence 
rates vary from 3% to 20%.2–4
Once injury is initiated, the disease process can result in a 
progressive course of irreversible organ destruction leading 
to exocrine pancreatic insufficiency, endocrine pancreatic 
insufficiency, and pain.5 In a natural history study of patients 
with chronic pancreatitis followed for nearly 10 years, 141 of 
311 (45%) patients developed exocrine pancreatic insuffi-
ciency, 117 of 311 (38%) patients developed endocrine pan-
creatic insufficiency, and up to 202 of 311 (65%) patients had 
pain.6 The syndrome of chronic pancreatitis pain, in conjunc-
tion with the patient’s pancreatic exocrine and endocrine 
insufficiency, can affect a number of quality-of-life issues.7–9 
This has been recently demonstrated in a well-designed case-
control study where both physical function and mental 
function were significantly lower in chronic pancreatitis 
patients than their corresponding cohort of control subjects.10 
These issues in turn can be exacerbated by the therapeutic 
interventions used to treat them. For example, narcotics may 
relieve pain, but interfere with everyday activities causing 
deterioration in the patient’s quality of life. Therefore, to truly 
evaluate the impact of therapy in this group of patients, one 
must evaluate quality of life with every intervention.11,12
Unfortunately, there are no disease-specific instruments 
currently available in the literature to measure quality of 
life in chronic pancreatitis patients.13 A review of the lit-
erature reveals that an abstract for a disease-specific 
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chronic pancreatitis instrument was developed in 1995.14 
However, there has been no subsequent follow-up study or 
validations of this instrument in any peer-reviewed journal 
to date. Three generic instruments have occasionally been 
used in this population. These include the following: (1) 
the McGill pain questionnaire, (2) the Medical Outcomes 
Study Short Form-36 (SF-36) Health Survey, and (3) the 
European Organization of Research and Treatment of 
Cancer (EORTC QLQ-C30 and QLQ-PAN26) scale.15–17 
Yet, each of these instruments presents deficiencies and 
shortcomings hindering their use in this group of patients. 
The McGill pain questionnaire, for example, is an instru-
ment that was developed to focus solely on evaluating the 
impact of pain on quality of life.15 As a result, it does not 
cover the wide range of problems that affect quality of life 
in chronic pancreatitis patients. Furthermore, it has never 
been psychometrically tested in this population of patients 
making its use here somewhat questionable. The SF-36 is 
an instrument that was developed to evaluate the impact of 
chronic medical illnesses on quality of life. Unfortunately, 
it too has its own set of limitations. In its only psychomet-
ric evaluation study in patients with chronic pancreatitis, it 
has been found to be reliable with Cronbach’s alpha score 
of 0.82, but lacking sensitivity as demonstrated by signifi-
cant ceiling and floor effects.16 Furthermore, it has only 
been evaluated in a Bavarian population of patients indi-
cating limited generalizability to our US population. The 
EORTC QLQ-C30/QLQ-PAN26 is an instrument that was 
developed for pancreatic cancer making its role in the 
evaluation of a chronic benign condition suspect. In fact, 
in its only psychometric evaluation in patients with chronic 
pancreatitis, it was found to have a number of significant 
limitations: (1) its study population was too small (n = 66) 
with insufficient numbers for an appropriate evaluation; 
(2) multiple cultures were involved, but no cultural adapta-
tions identified; and (3) internal consistency in some items 
revealed that Cronbach’s alpha score was extremely low 
(0.18), but the items were never adjusted.17
The goal of this study was to develop a disease-specific 
instrument for the evaluation of quality of life in this group 
of patients.
Materials and methods
Our study is divided into three parts: an instrument develop-
ment phase, a content validation phase, and a precognitive 
testing phase.18
Instrument development phase
This phase of the study was accomplished through the use of 
a qualitative descriptive study using focus groups to collect 
items that were felt to impact quality of life in chronic pan-
creatitis patients. Those patients who were concerned about 
disclosure and did not wish to participate in focus group ses-
sions but still wanted to be part of the study were offered 
one-on-one interviews. No one participated in both types of 
sessions.
Patient selection. Following Institutional Review Board (IRB) 
approval of the protocol (Docket no. H-12787), patients from 
the pancreatitis clinic of a large medical center in the North-
eastern United States were invited to participate in this study. 
Those who were interested and signed an informed consent 
were recruited into the study if they met the inclusion/exclu-
sion criteria as outlined in Table 1. Studies have shown that 
these diagnostic criteria provide a sensitivity of 80%–84% 
and a specificity of 90%–100% compared to histology or sur-
gical pathology.19,20
Setting. The focus groups and individual interviews were 
held outside the hospital environment, in local libraries 
where rooms were rented to ensure privacy and to avoid any 
hospital setting influences.21,22
The sessions were conducted by two members of the 
research team: a facilitator and an observer (scribe) neither 
of whom had been involved in the medical care of the 
patients to avoid any potential bias.23 The facilitator has her 
master’s degree in education and is a licensed social worker 
who has had prolonged experience in management of focus 
group research and interviews in the field of health care and 
education. The observer was a research assistant with a 
master’s degree in education and has been a research 
Table 1. Inclusion–exclusion criteria for chronic pancreatitis patients.19,20
Inclusion criteria Exclusion criteria
Patient must have abdominal pain, not related to other 
identifiable etiologies in conjunction with one of the following 
two features:
(a)  Presence of pancreatic calcification as demonstrated by an 
imaging study such as CT scan or KUB imaging
(b)  Presence of five out of nine criteria of pancreatic injury by 
endoscopic ultrasound in conjunction with a positive secretin 
stimulation test to confirm pancreatic insufficiency
Patient to be excluded from the study if they have one of the 
following features:
(a) Age less than 18 years
(b)  Comorbidities such as end-stage cancer (estimated survival 
< 6 months), HIV (T4 cell count < 50), end-stage congestive 
heart failure, end-stage chronic obstructive pulmonary 
disease, uncompensated cirrhosis, renal failure (on dialysis 
or with CrCl < 25), or preexisting diabetes mellitus
(c) Non-English speaking
CT: computer tomography; KUB: kidney–ureter–bladder; CrCl: creatinine clearance.
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assistant to the facilitator in similar projects in the past. The 
focus group sessions were small (four to five participants) 
to maximize patient interactions.22 Sessions lasted 1–2 h. 
The facilitator followed a semi-structured interview guide 
(Table 2) to stimulate participants’ discussion about the 
impact of chronic pancreatitis on essential elements of their 
quality of life. This interview guide was developed by the 
facilitator and the primary author in accordance with the 
Wilson and Cleary24 theoretical framework. According to 
the Wilson and Cleary model, one’s quality of life depends 
on the following three components: (1) characteristics of 
the individual which are impacted by two major domains 
(physical function and emotional function), (2) characteris-
tics of the environment which are impacted by one major 
domain (social/role function), and (3) one’s overall sense of 
well-being which is impacted by one major domain based 
on nonmedical factors. These three components are 
impacted by disease processes and impact one’s quality of 
life. Therefore, to meet the theoretical framework of the 
Wilson and Cleary model, the interview guide included 
questions that addressed these five major areas: physical 
function, emotional function, social function, role function, 
and general health function. However, to allow as much 
patient input as possible and to obtain a greater wealth of 
information regarding the impact of chronic pancreatitis on 
the patients, an open-ended question was included in the 
guide: “Has chronic pancreatitis affected anything else in 
your life that we have not discussed?” (Table 2). 
Brainstorming and synectics were two of the many group 
exercises that were used during the sessions to encourage 
this process.22 These are exercises used to simultaneously 
create a noncritical atmosphere while forcing participants 
to think away from traditional modes of analysis and more 
into creative and innovative modes.22 The individual inter-
view was conducted using the same set of questions as the 
focus groups (Table 2).
Data collection. Both the demographic characteristics and 
the clinical characteristics were collected using a self-
report questionnaire and confirmed through the patients’ 
medical records by our research nurse. The demographic 
characteristics included age, sex, race/ethnicity, marital sta-
tus, level of education, and employment status. The clinical 
characteristics included the following: (1) exocrine gland 
function as reflected by body mass index (BMI), albumin, 
symptom history (diarrhea) and need for pancreatic enzyme 
therapy; (2) endocrine gland function as reflected by use of 
medications for diabetes mellitus; (3) level of pain caused 
by pancreatitis as reflected by the need for narcotic ther-
apy; (4) etiology of pancreatitis; and (5) health-related 
behaviors included history of smoking, alcohol use, and 
use of narcotics. The data for these behaviors were col-
lected based on whether the patients were actively using 
these substances at the time of the study (yes or no). No 
attempts at quantification or past use were explored in our 
questionnaire.
Qualitative data were collected through focus groups and 
individual interviews as previously described. The interview 
content was transcribed using notes from the sessions sup-
plemented by audiotaped recordings.22 Participants’ own 
words were used to ensure the intensity and quality of their 
concerns and experiences. Interview data were summarized 
by transferring transcribed interview notes to 3 × 5 in2 index 
cards. Each card contained one item or idea linked only to 
date and time of focus group session/interview to ensure 
anonymity.
Data management. Demographic data and clinical character-
istics were entered into a Microsoft Office Excel 2007 
spreadsheet. Transcribed interviews and session summaries 
were entered into a Microsoft Office Word 2007 files.
Data analysis. Demographic and clinical characteristics of all 
patients who met the inclusion/exclusion criteria were 
Table 2. Semi-structured guide for focus group sessions and 
individual interviews.
Introduction
The moderator introduces himself or herself and discusses the 
purpose of the interview/focus group. He or she also introduces 
the scribe and the need to take notes as well as tape the 
session. He or she also presents the format and methods of data 
collection.
1. Opening question
Tell us your first name and anything else that you want to share 
with us about yourself
2. Introductory question
How long have you had chronic pancreatitis?
3. Transition questions
How has chronic pancreatitis changed your life?
Are there any particular symptoms that are most bothersome? 
(pain, nausea, vomiting, and diarrhea)
4. Key questions
Has chronic pancreatitis affected your physical function? How?
Has it affected your emotional function? How?
Has it affected your social function? How?
Has it affected your role function? How?
Has it changed your general health function? How?
5. Ending questions
Has chronic pancreatitis affected anything else in your life that we 
have not discussed?
How could we help you improve your life?
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analyzed by descriptive statistics. Continuous variables were 
analyzed by means and standard deviations. Categorical 
variables were analyzed by frequency, percent, cumulative 
frequency, and cumulative percent. Due to the small sample 
size, differences between patients who agreed and declined 
to participate were compared using Wilcoxon rank test for 
continuous variables and by Fisher’s exact test for categori-
cal variables.
Item generation. Qualitative data from interviews and 
focus groups were analyzed following each session using 
a modified concept mapping technique to generate key 
themes.25 First, index card items were sorted into piles of like 
statements. This process was performed in the presence of 
three analysts: the primary author, the focus group leader, and 
the scribe, to maximize reliability of coding and to minimize 
bias. Second, the major concepts were identified based on 
ideas represented by each of the items. This entire process 
was repeated until data saturation was reached.26
Item reduction. Once the item list was developed, the 
three team members (the primary author, the focus group 
leader, and the scribe from the item generation study) met 
to limit the large number of items within each domain. The 
item reduction was accomplished as described by the Krip-
pendorf27 method. First, each item was generated during the 
focus group and interview session was examined for content 
(n = 50). If all three members of the team felt that the item’s 
content was overlapping by more than 75% with another, 
the more comprehensive item was kept and the lesser item 
was removed. However, every effort was made to avoid the 
elimination of unique items.
Formatting the instrument. The reduced list of items that 
were identified was formatted into questions to produce a 
self-administered instrument for the evaluation of quality of 
life in this group of patients.28 Each question stem was based 
on a single construct from the items generated from parts 1 
and 2 of this phase of the study. The phrasing of the question 
followed a number of rules:28 (1) it was written at a sixth-
grade reading level with less than 20 words; (2) it was put 
together in a clear concise fashion with one idea/concept per 
question; (3) double negatives were avoided; (4) universal 
words were avoided; and (5) each question covered a spe-
cific time frame, the previous 4 weeks, to ensure specificity.
Responses to the questions were formatted using a four- 
or five-response option Likert scale with one exception. The 
question addressing pain severity had a 10-point response 
scale.
Content validation phase
Following IRB approval (Docket no. H-12958), physician 
experts in the field of pancreatology were asked to evaluate 
the instrument through an online survey.29
Target population. The physician experts were selected from 
the physician registry of the American Pancreatic Associa-
tion. Of 230 registered physicians specializing in pancreatic 
disease, 35 were purposefully selected as a convenience sam-
ple to represent various geographical regions of practice.
Survey administration. Once selected, each expert was invited 
by e-mail to participate.30 Those who did not respond to our 
invitation initially were re-invited. After three attempts, they 
were excluded from the study. The web-based survey 
included the following items: (1) cover letter to briefly intro-
duce the study, (2) instructions on evaluating the instrument 
for relevance and clarity, and (3) a modified questionnaire 
that included the 40-item Pancreatitis Quality of Life Instru-
ment (PANQOLI) and 5 items from the Health Care Rela-
tionship (HCR) Trust Scale. The HCR Trust Scale is an 
instrument that was developed by one of the authors of this 
article (C.B.) to evaluate the issue of trust between patients 
and their health-care providers. It would not be related to the 
impact of chronic pancreatitis on quality-of-life issues; how-
ever, it was added in this context as part of the instrument to 
determine whether or not the physicians were able to distin-
guish between items that measure quality of life and those 
that measure trust.31 Furthermore, in order to help truly test 
the physicians’ ability to distinguish between it and the PAN-
QOLI, it was not labeled or identified separately. Item rele-
vance was rated on a Likert scale from 0 (not relevant) to 3 
(highly relevant). Clarity was rated on a yes/no scale.
To ensure privacy, login entry was used. This also helped 
prevent multiple entries.30 Once each physician completed 
the survey, they were not allowed further access into the 
web site.
Data collection. After each expert completed the web-based sur-
vey, the data were transmitted electronically from the web site 
to our center and entered directly into an Excel spreadsheet.
Data analysis. Only completed surveys were analyzed. To 
evaluate potential bias in selecting expert physicians, the 
characteristics of those who agreed and declined to partici-
pate in the study were compared in terms of region of prac-
tice. Differences between experts who agreed and declined 
to participate were analyzed by chi-square tests.
The relevance of items were assessed by their average 
item-level content validity index (I-CVI), which was calcu-
lated by summing all experts’ scores on item relevance or 
clarity and dividing by the number of experts.32 Items were 
considered relevant if they were identified as 2 or 3 on the 
scale by the majority of experts (i.e. if 7 physicians partici-
pated, it would require that 5 out of 7 considered the item 
valid by giving it a score of 2 or 3; this would translate into 
an average I-CVI of 5/7 physician acceptance rate which 
would be >0.714, and the item would be kept). Those items 
that would be kept were then evaluated for clarity (yes/no). 
Items deemed to be clear by the majority of experts (5/7, i.e. 
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average I-CVI > 0.714) were kept unchanged, otherwise they 
were modified. The number of items accepted and/or rejected 
by expert physicians on the PANQOLI (items 1–40) and 
HCR Trust Scale (items 40–45) were assessed by descriptive 
statistics as described above. Differences in frequency of 
accepted and/or rejected items between the two scales were 
compared by chi-square test.
Precognitive testing phase
Content validation of the instrument by physicians, how-
ever, is insufficient. Studies have shown that using hetero-
geneous expert panels of patients provides a more thorough 
validation of an instrument, making it more relevant to the 
target population.33 Therefore, in this phase of the study, 
one-on-one interviews were used to re-evaluate the 
PANQOLI for completeness and clarity by patients. This 
does not replace psychometric testing, but it does ensure 
that patients do understand the instrument and do support 
its validity and comprehensiveness before psychometric 
testing is conducted.
Patient selection. Following IRB approval of the protocol, all 
10 patients who had previously participated in the first part 
of the study and had signed an informed consent were re-
invited to participate.
Setting. All cognitive pretesting sessions were conducted as 
one-on-one interviews held outside the hospital environ-
ment, in local libraries where rooms were rented to ensure 
privacy and to avoid any hospital setting influences.21,22 
Prior to the interview, each patient was asked to fill out a 
demographic data sheet as in the first part of the study. Dur-
ing each interview, as discussed in the first part of the study, 
the session was conducted by two members of the research 
team: a facilitator and an observer (scribe) neither of whom 
had been involved in the medical care of the patients to 
avoid any potential bias.23 The interview session was con-
ducted one patient at a time to maximize patient interac-
tions.22 Each interview lasted 1–2 h. During the interview, 
the facilitator reviewed the modified instrument, as deter-
mined by the content validation phase of the study, one 
question at a time to address two areas of concerns: (1) rel-
evance of each item (0–3) and (2) clarity of each item (yes, 
no). At the end of each session, each patient was asked 
whether there were any additional items that they would like 
to include in the instrument.
Data collection. Qualitative data were collected in individual, 
audiotaped interviews led by a facilitator with an observer 
present to record notes. Interview data were based on notes 
taken by the observer and supplemented by the audiotapes.
After data were collected, they were double entered elec-
tronically into an Excel spreadsheet to ensure maximum 
accuracy.
Data analysis. The relevance and clarity of the PANQOLI 
items were assessed as in the previous section of the study by 
their average I-CVI. This was calculated by summing all 
patients’ scores on item relevance or clarity and dividing by 
the number of patients. Items were considered relevant if 
they were identified as 2 or 3 on the scale by the majority of 
patients (i.e. if 4 patients were interviewed and 3 out of the 4 
patients rated the item as 2 or 3, then the acceptance rate 
would be 3/4, giving an average I-CVI > 0.75, meaning the 
item is to be kept). Items were deemed unclear if they were 
identified as such by the majority of patients (3/4, i.e. aver-
age I-CVI > 0.75), and at that point, they would be modified 
and re-evaluated at the subsequent patient interview. Once 
data saturation was reached, this part of the study was 
terminated.
Results
Part A: instrument development phase
Participant characteristics. In this part of the study, 64 chronic 
pancreatitis patients at the UMass Memorial Pancreatitis 
clinic were identified and consented. Of 64 patients, 13 were 
excluded from the study due to lack of confirmatory evi-
dence for chronic pancreatitis. The remaining 51 patients 
met the inclusion/exclusion criteria and were invited to take 
part in the study. Of the 51 patients who agreed to partici-
pate, only 10 did so (20% response rate). Reasons for not 
participating were that patients were too busy (n = 25), too ill 
(n = 3), could not be contacted to set up an appointment (n = 
9), and did not keep their appointment (n = 4).
Demographics of patients who did agree to participate (n = 
10) and those who did not (n = 41) were compared (Table 3). 
Some minor sociodemographic differences were noted 
between these two groups. These included differences in age 
(55.60 vs 47.90 years; p = 0.06), employment status (30% 
fully employed vs 12%; p = 0.10), and alcohol use (30% 
active use vs 61%: p = 0.15). Although none of these was 
statistically significant, it is noteworthy to realize that those 
patients who participated in the study may have been slightly 
older, more likely employed full time, and not actively using 
alcohol compared to those who did not participate. However, 
the only significant differences noted between the two groups 
were etiology of pancreatitis and diarrhea. Yet, markers of 
severity such as nutrition, albumin, use of pancreatic enzymes, 
prevalence of insulin-dependent diabetes, and narcotic use 
did not show significant differences between the groups. 
Those who agreed to participate (n = 10) were scheduled for 
one of two focus group sessions (n = 4 and n = 5). One indi-
vidual opted for and was granted a personal interview rather 
than a focus group session (n = 1), based on personal 
preference.19
Data saturation. At the end of the first focus group, patients 
identified 31 areas in which chronic pancreatitis affected 
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Table 3. Demographic and clinical characteristics of eligible patients who agreed and refused to participate in the item development 
part of the study.a
Variable Agreed  
(n = 10)
Refused (n = 41) p valueb
Demographics
 Age (years), mean ± SD 55.60 ± 14.74 47.90 ± 12.60 0.06
 Median 58 48  
Gender
 Male 2 (20%) 14 (34%) 0.47
 Female 8 (80%) 27 (66%)  
Race
 White 9 (90%) 32 (78%) 0.88
 Black 1 (10%) 3 (7%)  
 Hispanic 0 (0%) 2 (5%)  
 Asian 0 (0%) 4 (10%)  
Marital status
 Single 1 (10%) 14 (34%) 0.35
 Married/partnered 6 (60%) 18 (44%)  
 Divorced/widowed/separated 3 (30%) 9 (22%)  
Employment
 Full time 3 (30%) 5 (12%) 0.10
 Part time 1 (10%) 0 (0%)  
 Unemployed 3 (30%) 18 (44%)  
 Disabled 1 (10%) 13 (32%)  
 Retired 2 (20%) 5 (12%)  
Education level
 Secondary school 0 (0%) 1 (2.4%) 0.51
 Commercial/vocational school 7 (70%) 33 (80.5%)  
 College/university 3 (30%) 7 (17.1%)  
Health-related behaviors
 Smoking (yes/no) 4/6 (40%/60%) 25/16 (61%/39%) 0.30
 Alcohol use (yes/no) 3/7 (30%/70%) 25/16 (61%/39%) 0.15
Clinical characteristics
 Pancreatitis etiology
  Alcohol 1 (10%) 14 (34.2%) 0.02
  Idiopathic 4 (40%) 20 (48.8%)  
  Autoimmune 2 (20%) 1 (2.4%)  
  Triglyceridemia 0 (0%) 2 (4.9%)  
  Cystic fibrosis 0 (0%) 1 (2.4%)  
  Hereditary 1 (10%) 0 (0%)  
  Biliary 2 (20%) 0 (0%)  
  Divisum 0 (0%) 1 (2.4%)  
  Cyst/other 0 (0%) 2 (4.9%)  
 Diarrhea (yes/no) 6/4 (60%/40%) 6/35 (15%/85%) 0.006
 BMI (kg/m2), mean ± SD 25.15 ± 5.02 25.19 ± 5.65 0.96
  Median 23.35 24.5  
 Albumin (g/dL), mean ± SD 3.55 ± 0.78 3.63 ± 0.60 0.89
  Median 3.75 3.7  
 Pancreatic enzymes (yes/no) 9/1 (90%/10%) 26/15 (63.5%/36.6%) 0.14
 Narcotics (yes/no) 5/5 (50%/50%) 30/11 (73%/27%) 0.25
 Diabetes mellitus (yes/no) 4/6 (40%/60%) 11/30 (27%/73%) 0.45
SD: standard deviation; BMI: body mass index.
aUnless otherwise indicated, values are expressed as the number of participants and percentages (%). Percentages may not add to 100 due to rounding.
bGroup differences for categorical and continuous variables were computed using Fisher’s exact test and the Wilcoxon rank-sum test, respectively.
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their quality of life including the following: physical func-
tion (n = 10), social/role function (n = 7), emotional function 
(n = 6), general health function (n = 3), economic function (n 
= 3), spiritual function (n = 1), and stigma of their condition 
(n = 1) (Table 4). At the end of the second focus group, 
patients cited 31 areas, but only 19 of 31 were new (61%; 
Table 4). This included the following: physical function (n = 
8), social/role function (n = 8), emotional function (n = 6), 
general health (n = 1), economic function (n = 5), spiritual 
function (n = 2), and stigma of their condition (n = 1). At the 
end of the individual interview, 17 areas were cited, and of 
these only 2 of 17 were new (12%; Table 4). This included 
the following: physical function (n = 5), social/role function 
(n = 4), emotional function (n = 5), general health (n = 1), 
economic function (n = 1), spiritual function (n = 0), and 
stigma of their condition (n = 1). Since the amount of new 
information was decreasing over the three sessions (100%, 
61%, and 12%, respectively) and since only 12% of the 
information was new in the third session, it was decided that 
a saturation point had been reached and that this would be a 
reasonable point to end data collection for this phase of the 
study.
Item generation. Analysis of qualitative data from the two 
focus groups and one interview identified 50 items related to 
the quality of life of patients with chronic pancreatitis (Fig-
ure 1). Of these, 40 items were related to generic quality-of-
life issues: 13 were identified as impacting physical function, 
13 as impacting social/role function, 11 as impacting emo-
tional function, and 3 as impacting general health function.
Within the domain of physical function, participants 
described 13 symptoms that impacted their day-to-day 
functioning. Paramount among these was pain (n = 8). 
This seemed to impact patients the hardest: “I live with the 
pain every day, but when I am stressed, it makes it worst”; 
“it hurts sitting, it hurts to walk, and it hurts to lie down”; 
and “pain is all the time.” Another item that impacted 
physical function dramatically in this group of patients 
was diarrhea (n = 2): “losing dignity due to diarrhea and 
accidents from bowel movements” and “you always need 
to know where the bathroom is—you have to find out 
before you even go to a place.” Other items that were noted 
to impact physical function included nausea and vomiting 
(n = 4), inability to sleep (n = 3), dietary modifications (n 
= 3), number of hospital admissions (n = 3), weight loss (n 
= 2), number of pills used (n = 2), heartburn (n = 1), con-
stipation due to pain meds (n = 1), and number of proce-
dures/surgery (n = 1).
Social/role function was the second key conceptual 
domain being impacted by chronic pancreatitis with 13 items 
identified. Within this domain, participants seemed to be 
most impacted by their inability to fulfill their parental role 
(n = 7): “Having an attack, kids don’t understand; they’re 
scared,” “can’t volunteer at my kid’s school,” and “kids 
neglect their own lives to help me out.” Participants also 
discussed their inability to maintain their friendships (n = 
4)—“Not being able to make long range plans, like a trip or 
a vacation” and “friends have faded away, there’s not much 
to talk about and I can’t really go anywhere to eat with 
them”—and inability to maintain their spousal intimacy (n = 
2)—“my husband needs to be supportive, but sometimes I 
need to pull back away from him. It hurts both of us. 
Sometimes I lie to him about the severity of the pain that I’m 
in to spare him” and “I can barely function. I can’t do most 
of what I used to—no love making either.” Other items dis-
cussed by the patients included the following: lack of a social 
life (n = 4), stress on the family structure (n = 4), inability to 
drive (n = 2), poor self-care (n = 2), and inability to do house-
hold chores (n = 1).
Emotional function was the third major domain with 11 
items identified. Within this domain, study participants dis-
cussed depression (n = 3), hopelessness, and suicidal idea-
tion (n = 2): “I had lots of goals in life, now they are gone,” 
“now I don’t know …,” “I don’t take pride in my clothing or 
shopping anymore, priorities change … it comes on at any 
given time,” “I feel lonely,” “I think I feel good at first, then 
very sick and far away,” “nothing can help, I’m just dying,” 
“I wish I was dead,” “I don’t take pride in my clothing or 
shopping any more,” and “I had a lot of goals in life, now 
they are gone.” Numerous other emotions seemed to be 
raised by chronic pancreatitis. These include stress (n = 6), 
frustration (n = 3), anger (n = 2), embarrassment (n = 1), and 
fear (n = 1).
Another 10 items were identified, but these were impact-
ing new domains: 6 impacting economic function, 3 impact-
ing spiritual function, and 1 impacting stigma.
Economic function. Several (n = 6) participants discussed 
the lack of employment due to recurrent absenteeism and 
often the need to retire early due to their health condition 
as important concerns: “Employers don’t want to hire 
me”; “I had to retire early”; “the doctor said to work, my 
lawyer said not to …”; “I can’t work. If you tell people of 
your condition, they don’t want to hire you”; and “you get 
fired because you miss too much work … because of my 
condition.” Others raised concerns regarding the high 
cost of medicines (n = 5), the high cost of hospital/doctor 
bills (n = 3), and the high cost of healthy foods (n = 2).
Stigma (n = 1). The stigma associated with the diagnosis 
of chronic pancreatitis was mentioned by five of the par-
ticipants. They discussed their difficult experiences in the 
emergency room: “I’ve been dry and sober for 3 years and 
they still ask me if I’ve been drinking,” “… we are not 
drug seekers,” and “you need a personal advocate when in 
the ER (Emergency Room) … I’d rather be in labor!”
Item reduction. Items were deleted from the final pool if 
they were felt to be redundant by the three-member team 
(primary author, focus group leader, and scribe) as discussed 
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Table 4. Data saturation during the item development part of the study.
Item Discussed in focus 
group 1 (n = 4)
Discussed in focus 
group 2 (n = 5)
Discussed in personal 
interview (n = 1)
Impact on physical function
 Large number of pills New Old  
 Heartburn New  
 Diet changes New  
 Length of hospitalizations New Old  
 Pain New Old Old
 Stigma with alcohol New Old  
 Weight loss New  
 Can’t drive New Old
 Relish the rest of your life New
 Wears me down New Old
 Not knowing when pain is coming New  
 Nausea/vomiting New Old  
 Diarrhea New Old Old
 10 8 5
Impact on social/role function
 Unable to travel New Old  
 Daily plans interrupted by pain New Old
 Can’t drink New  
 No social life with friends New Old
 Can’t be with kids New  
 Absenteeism from work New Old  
 Hurts to do housework New Old
 Affects significant other New Old
 Relationships with friends changed New  
  Every day is constant interruptions 
because of meds
New  
 Unable to be a parent New  
 Can’t make plans New  
 Can’t be a bread winner New  
 7 8 4
Impact on emotional function
 Unable to work New Old  
 Anger New  
 Embarrassment New  
 Frustration with condition New Old
 Depression New Old
 Lonely New
 Fear of drug addiction New Old
 Feel handicapped New  
 Feel tired New  
 Fear of pain New  
 Stress New Old
 Suicidal thoughts New  
 6 6 5
Impact on general health
 Need to diet New  
 Physically draining New Old  
 Constipation New Old
  Patients unable to take care of 
other medical problems
 
 3 1 1
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Item Discussed in focus 
group 1 (n = 4)
Discussed in focus 
group 2 (n = 5)
Discussed in personal 
interview (n = 1)
Other areas impacted
 Economic impact
  Early retirement New Old
  Expensive child care support New  
  Expensive ER visits New  
   Increased medical costs for 
meds
New Old  
  Healthy foods are expensive New  
  Lost wages from absenteeism New  
  Unemployment New
3 5 1
 Spiritual impact
  Religion is a blessing New  
  Religion is a nightmare New  
  Can’t get to church New  
 1 2 0
 Stigmata
   Health-care professionals accuse 
patients of being drug addicts
New Old Old
 1 1 1
Total number of items 31 31 17
Number of items new 31 19 2
Percentage of new items 31/31 = 100% 19/31 = 61% 2/17 = 12%
ER: emergency room.
Table 4. (Continued)
in section “Materials and methods.” The reduced item pool 
consisted of 40 items (Figure 1).
Formatting the instrument. Each of the 40 items was for-
matted into a question as described in section “Materials 
and methods” (Table 5). This lead to the following distri-
bution of questions for the instrument: physical function 
(n = 17), social/role function (n = 8), emotional function 
(n = 8), general health function (n = 2), economic function 
(n = 3), religious/spiritual function (n = 1), and stigma (n 
= 1). The response was formatted into a 4- or 5-item Lik-
ert scale.
Part B: content validation phase
In this part of the study, 35 physician experts were recruited 
for content validation through the electronic survey described 
in section “Materials and methods.” Of 35 of these physi-
cians, 7 completed the item validation survey (acceptance 
rate of 20%). Experts who agreed and those who refused to 
participate did not differ significantly in geographic location 
of practice (p = 0.94).
All items with average I-CVI of >0.714 were included in 
the instrument. This resulted in a decrease in the number of 
items to 22 (Table 6). Of the 18 items that were removed, 
15 were thought to be redundant and 3 were felt to have no 
relationship with pancreatitis. This included items related 
to the impact of spirituality on chronic pancreatitis. The 
physician panel correctly identified all five HCR Trust 
Scale items as irrelevant to quality of life in patients with 
chronic pancreatitis. The physician panel also made two 
recommendations to improve the scale: (1) adding an item 
in the PANQOLI on the impact of chronic pancreatitis on 
patients’ sex life and (2) using a 5-point Likert response 
scale instead of a 4-point scale to offer patients a “no 
change” option. As a result, this lead to the formation of a 
23-item instrument with a 5-point Likert scale for each 
item, except for the first item on pain level which had a 
10-point scale (Figure 1).
Part C: cognitive pretesting phase
All 10 patients, who were involved in the first phase of the 
study, agreed to participate in this phase of the study. 
However, after four interviews, no new data were obtained 
and the cognitive pretesting phase of the study was termi-
nated. Based on this phase of the study, three of four 
patients believed that chronic pancreatitis did at times 
impact their spiritual function, and therefore, the spiritual 
item was reinserted back into the instrument. According 
to the patients, the rest of the instrument seemed compre-
hensive, clear, and did not require modifications. This 
resulted in a 24-item instrument with 5-item Likert scale 
(Figure 1).
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Table 5. Examples of questions formatted for the PANQOLI.
DIRECTIONS: The following items ask about your physical, social, economic, general, and emotional response to living with chronic 
pancreatitis. Please circle the number that corresponds with your best answer. When you answer each question, please let us know 
how you have felt in the past 4 weeks, as compared to the previous 4 weeks.
1. Over the last 4 weeks, the severity of your pain has been …
0 1 2 3 4 5
Not much slightly no slightly much
Applicable less less change more more
2. Over the last 4 weeks the severity of your vomiting has been …
0 1 2 3 4 5
Not much slightly no slightly much
Applicable less less change more more
3. Over the last 4 weeks, the severity of your nausea has been …
 0 1 2 3 4 5
Not much slightly no slightly much
Applicable less less change more more
4. Over the last 4 weeks, the severity of your diarrhea has been …
 0 1 2 3 4 5
Not much slightly no slightly much
Applicable less less change more more
5. Over the last 4 weeks, the amount of weight loss that you have experienced has been …
0 1 2 3 4 5
Not much slightly no slightly much
Applicable less less change more more
PANQOLI: Pancreatitis Quality of Life Instrument.
Figure 1. Instrument development flowchart.
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Discussion
Summary of main findings
Here, we report on the development of the first disease-spe-
cific instrument for evaluating quality of life in patients with 
chronic pancreatitis. This new instrument presents latent 
variables underlying health-related quality of life in chronic 
pancreatitis not seen in generic instruments nor in Wilson 
and Cleary’s24 model of patient outcomes. These include 
impact of disease on economic variable, on stigma, and on 
spirituality. Based on our study, what is being proposed is 
that in chronic pancreatitis patients, quality-of-life evalua-
tion must include these three items.
Strengths and limitations of the study
Before considering this new instrument for the evaluation of 
quality of life in chronic pancreatitis patients, one needs to 
address a number of study limitations. First, the results of 
Part A (item development) may have been compromised by 
the potential for selection bias, after all only 10 out of 51 
eligible patients were included in the study, and the small 
sample size. However, on closer examination, it seems that 
neither issue was significant:
1. Selection bias: although some minor sociodemo-
graphic differences were noted between the patients 
who did participate and those who did not, including 
age, employment status, and active use of alcohol, 
none of these was statistically significant. In fact, the 
significant differences between the two groups were 
the etiology of the disease, which is not related to the 
severity of the disease, and the prevalence of diarrhea 
(p = 0.002), which can be related to the severity of the 
disease (Table 3). However, an evaluation of other 
measures of chronic pancreatitis severity (e.g. diabe-
tes, albumin, and narcotic use) does not demonstrate 
significant differences between the groups, indicating 
that this difference in diarrhea may have been a spuri-
ous finding related to other confounding factors that 
were not measured (i.e. medications) rather than one 
related to differences in severity of the disease.
2. Small sample size: although large sample size is cru-
cial for quantitative studies, that is not always needed 
in qualitative studies. In qualitative studies, the most 
important factor is whether data are collected from 
enough participants to reach data saturation. A review 
of the data collected reveals that 31 of 31 (100%) 
were new items introduced during the first session, 
19 of 31 (61%) were new items introduced during the 
second session, and only 2 of 17 (12%) were new 
items introduced during the third session (Table 4). 
Based on this, the data had reached a saturation point 
implying that the sample size used was sufficient in 
providing information for the question at hand.
Table 6. Content validation of PANQOLI items by physician 
panel (n = 7).
Item 
number
Theme Physician panel Decision
Clarity (%) Relevance (%)a
1 Pain 85.7 100 Accept
2 Pain 100 85.7 Accept
3 Pain 100 85.7 Accept
4 Vomiting 85.7 28.6 Reject
5 Vomiting 85.7 28.6 Reject
6 Nausea 85.7 71.4 Accept
7 Nausea 85.7 71.4 Accept
8 Diarrhea 85.7 71.4 Accept
9 Diarrhea 85.7 85.7 Accept
10 Anorexia 100 85.7 Accept
11 Anorexia 71.4 85.7 Accept
12 ER visits 100 100 Accept
13 ER visits 100 42.9 Reject
14 Admissions 100 85.7 Accept
15 Admissions 85.7 42.9 Reject
16 Sleep 71.4 57.2 Reject
17 Sleep 100 71.4 Accept
18 Family 100 85.7 Accept
19 Family 100 71.4 Accept
20 Friends 100 42.9 Reject
21 Friends 71.4 42.9 Reject
22 Children 85.7 85.7 Accept
23 Children 85.7 85.7 Accept
24 Spouse 85.7 71.4 Accept
25 Spouse 85.7 71.4 Accept
26 Work 71.4 100 Accept
27 Finances 71.4 42.9 Reject
28 Money 57.1 42.9 Reject
29 Health 100 100 Accept
30 Health 71.4 42.9 Reject
31 Spiritual 85.7 0 Reject
32 Stigma 85.7 14.3 Reject
33 Stress 100 71.4 Accept
34 Stress 100 57.2 Reject
35 Depression 85.7 71.4 Accept
36 Depression 71.4 57.2 Reject
37 Frustration 85.7 57.2 Reject
38 Frustration 71.4 57.2 Reject
39 Anger 85.7 57.2 Reject
40 Anger 85.7 57.2 Reject
41 HCR Trust Scale 71.4 0 Reject
42 HCR Trust Scale 42.9 0 Reject
43 HCR Trust Scale 57.1 14.3 Reject
44 HCR Trust Scale 85.7 14.3 Reject
45 HCR Trust Scale 85.7 42.9 Reject
PANQOLI: Pancreatitis Quality of Life Instrument; ER: emergency room; 
HCR: Health Care Relationship; df: degree of freedom.
aPANQOLI items 1–40 and HCR Trust Scale items 41–45 differed signifi-
cantly for physicians (p = 0.0014, chi-square 10.20, df = 1).
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A second potential study limitation could have been 
“interpreter bias.” In qualitative analysis, subjective inter-
pretation of data is always involved, especially when deter-
mining how people felt about their disease and how it 
impacted them. While this issue cannot be completely 
excluded, it was minimized in this study by avoiding data 
editing during the item development phase of the study and 
by involving multiple analysts in the evaluation phase of the 
study (the primary author, the focus group leader, and the 
scribe).
A third potential study limitation could have been design 
issues related to the content validation part of the study such 
as reliability and accuracy of data collected from the Internet, 
the expertise of the selected physicians, and the potential 
likelihood of obtaining our results by chance rather than 
knowledge and true understanding of the subject at hand. 
Carefully designed controls in our study methodology were 
used to address these concerns:30
1. To ensure the reliability and accuracy of our data set, 
SurveyMonkey was used as our web site with spe-
cific log-on codes. This approach ensured that only 
our selected physicians had access to the survey and 
that each of them only had single use capabilities.
2. To evaluate the quality of our panel of physicians, we 
administered the 5-item HCR Trust Scale in conjunc-
tion with the PANQOLI items without separating them 
and without informing the panel members. This 
blinded control methodology allowed us to truly test 
the ability of our panel of experts confirming their true 
knowledge on the subject matter. Our panel of physi-
cians rejected all five HCR Trust Scale items, but only 
18 of 40 PANQOLI items (p = 0.001) (Table 6).
3. To ensure that our content validation was not merely 
due to chance agreement, we used a cutoff value of 
>0.71 (five of seven physicians agreed on the rele-
vance of an item). Using binomial distribution calcu-
lations, this would make the likelihood of chance 
agreement between each of our panels small, but not 
negligent (less than 0.164 for our physician panel and 
less than 0.375 for patients).
A fourth study limitation is that rather than recruit new 
patients, the same group of patients were asked to participate 
in the cognitive pretesting phase of the study as in the instru-
ment development phase. Although this was a choice that we 
made to allow patients to elaborate more fully on their initial 
thoughts and feelings gathered during the first phase of the 
study, we may have limited the potentially broader range of 
answers and comments that we could have obtained had we 
recruited a new group of patients. To overcome this potential 
internal bias, and learning effect that may have developed as 
a result of our methodology, we plan to obtain further input 
from patients at other sites before we undergo our next phase 
of instrument testing.
Finally, one needs to consider whether the newly identi-
fied variables which include economic factors, stigma, and 
spirituality may be spurious findings. A review of the litera-
ture, however, shows that all these items have been identified 
as items of concern for chronic pancreatitis patients else-
where in the literature. A survey, conducted at four US pan-
creas centers of 111 chronic pancreatitis patients, revealed 
that, when asked about their economic status, work experi-
ence is impacted in 74% of patients because of their disease 
process and that only 37% are able to maintain steady 
employment because of it.8 Similarly, when asked regarding 
their experience in the health-care system, 80% reported that 
on at least one emergency department visit, they had not 
been treated with respect or dignity; furthermore, 45% stated 
that they were labeled as alcoholic and 29% as drug seekers 
simply based on their chronic pancreatitis condition at one 
point during their emergency department visit. Similarly, the 
relationship between religion–spirituality and chronic pain 
syndromes have been demonstrated in other studies.34
Implications for future research
In view of these findings, one must consider this new instru-
ment to be a useful instrument for the evaluation of quality of 
life in chronic pancreatitis patients. However, since it was 
developed at a single center, its impact nationwide may not 
be apparent until nationwide testing is performed to deter-
mine its reliability and its construct validity at a national 
level. Therefore, national psychometric testing would need 
to be performed prior to its clinical use.
Conclusion
PANQOLI is the first disease-specific instrument to be 
developed for chronic pancreatitis. Based on our initial 
study, it does represent variables not found in generic instru-
ments for the evaluation of quality of life that may be unique 
to chronic pancreatitis patients (economic variables, stig-
mata, and spiritual factors). However, its use nationwide 
would have to await its psychometric evaluation at other 
centers to assess its reliability and construct validity using a 
different cohort of chronic pancreatitis patients.
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